# Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

> **NCT05034770** · — · COMPLETED · sponsor: **Emine Dundar Ahi, MD** · enrollment: 45 (actual)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **OTHER:** major ozone autohemotherapy

## Key facts

- **NCT ID:** NCT05034770
- **Lead sponsor:** Emine Dundar Ahi, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034770, "Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05034770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
